Sample preparation for solid-state NMR

Figures
-1 ESI-MS spectra confirming the presence of 1 and 1 in the two peak fractions shown in Figure 1 of the main text. 9, 162.5, 148.6, 146.9, 122.7, 115.3, 85.0, 51.2, 48.4, 43.7, 42.15, 42.13, 40.7, 37.1, 36.8, 36.7, 35.2, 32.7, 28.7, 26.6, 22.6, 21.5, 21.0, 16.6 
Synthesis of 3R-bufalin (1)
Bufalone (76.8mg, 0.2mmol) was dissolved in anhydrous tetrahydrofuan (5 ml) in a round bottom flask. Sodium borohydride (NaBH 4 ) was added, stirring constantly to completely dissolve. The solution was stirred for one hour at room temperature. Then 5ml water was added slowly to the reaction solution.
Ethyl acetate (5ml  2) was used to extract the mixture and the solvent was removed under reduced pressure. The crude reaction mixture was purified by preparative HPLC, eluting with 45% acetonitrile to yield 3R-bufalin (58.0 mg, yield 75%). 4, 160.3, 148.4, 146.8, 122.7, 115.1, 85.0, 60.9, 51.0, 48.2, 42.1, 41.6, 40.5, 36.6, 36.5, 35.4, 32.6, 28.6, 26.7, 26.4, 25.4, 22.9, 21.3, 20.9, 16.4 148.4, 146.8, 122.7, 115.2, 85.3, 62.6, 60.3, 51.1, 48.2, 42.5, 41.4, 40.8, 36.4, 35.4, 35.1, 32.7, 31.0, 28.6, 27.1, 25.3, 23.4, 21.5, 21.1, 16.4 3, 148.4, 146.8, 122.7, 115.1, 85.3, 62.3, 54.9, 51.1, 48.2, 42.3, 40.8, 36.5, 35.7, 35.4, 32.7, 30.2, 28.6, 28.5, 26.5, 23.7, 22.7, 21 149.4, 147.4, 122.7, 114.2, 89.7 (d, J = 47.6Hz), 83.9, 78.8, 78.4, 70.4, 69.9, 62.8, 61.3, 60.9, 50.1, 48.0, 41.37, 41.34, 39.9, 35.7, 35.4, 34.6, 32.1, 31.2, 28.4, 27.2, 24.1, 23.3, 21.3, 20.8, 16.6 83.4, 78.9, 78.4, 70.6, 70.0, 62.7, 61.4, 56.1, 50.1, 48.1, 41.4, 40.4, 36.1, 35.4, 35.3, 32.0, 30.4, 29.0, 28.5, 27.0, 24.5, 23.8, 21.2, 20.8, 16.7 
3R-bufalin
Synthesis of 3-trifluoromethyl derivatives 6 and 6.
Bufalone (2, 0.2 mmol) was dissolved in anhydrous THF (5 ml), then catalytic amount of n-tetra butylammonium fluoride (approx. 6 mg) was added. 6, 150.5, 148.6, 123.9, 115.5, 84.5, 72.1 51.3, 49.3, 42.3, 41.4, 41.3, 40.2, 39.9, 37.4, 36.2, 35.6, 33.1, 30.9, 30.8, 29.7, 27.3, 24.5, 22.3, 17.9; 19 F NMR (CDCl 3 , 282. 150.5, 148.6, 123.9, 115.5, 84.6, 73.0, 51.4, 49.3, 42.4, 41.6, 42.3, 39.5, 37.1, 35.3, 34.8, 33.5, 33.3, 29.6, 29.0, 27.5, 24.2, 22.3, 21.9, 17.9; 19 F NMR (CDCl 3 , 282.4 MHz) δ -77.08.
X-ray analysis of 5
X-ray diffraction data were collected on an Gemini S ultra spharrie CCD diffractometer using graphite monochromated radiation ( = 1.54178 Å) at room temperature. The crystal structures were elucidated by direct methods using SHELXS-97 and refined by full-matrix least-squares method on F 2 using SHELXS-97. In the structure refinement, non-hydrogen atoms were refined 
Details of the kinetic analysis of inhibition (1) Experimental details of the bufadenolide inhibition
Stock solutions of the inhibitors, typically 10 mM, were prepared in DMSO.
The inhibitory effects of bufadienolides on NKA were determined essentially as previously reported 9, 10 . In brief, NKA is preincubated at 37 o C for 2 hours in the presence of 3 mM MgCl 2 , 3 mM Na-phosphate and 40 mM Tris (pH 7.0) with increasing concentrations of inhibitor. The residual NKA activity is subsequently determined by 40-fold dilution into a standard ATPase assay medium in triplicate, see section SI 11. For each inhibitor concentration the residual activity was determined in two or three independent experiments and the error bars in Fig. 4 indicate the standard deviation. Data in Fig. 4 are given as percent of the NKA activity in the absence of inhibitor (see legend to Fig. 4 for details).
The maximal DMSO concentration of 2.5% after dilution into the NKA incubation medium was 2.5 %. Control experiments showed that incubation with 2.5% DMSO for 2 hours at 37 o C leads to less than 10% inhibition of Na + , K + -ATPase activity.
(2) Detailed explanation of the kinetic analysis of inhibition
The interaction between bufalins (I) and Na The binding of I to E is described by a dissociation constant
The conformational change E•I ↔ E•I* is described by an equilibrium constant
After equilibrium is attained by preincubation of the enzyme and inhibitor, the residual Na
In control experiments without preincubation we have observed that addition of Compound 5β to the ATPase assay medium directly indeed inactivates the Na,K-ATPase activity and with the same potency as observed in Figure 4C (data not shown).
It should be noted that the errors in the values for K Diss,low in the present experiments (see Table 1 ) are too large to allow meaningful correlation between the low-affinity inhibitory potency and the conformation of the inhibitor.
Sample preparation for solid-state NMR
Na + ,K + -ATPase membranes (13 nmol protein) were prepared as a pellet by centrifugation at 100,000 g for 30 min at 4°C, resuspended in 1 ml incubation medium, and incubated with 16 nmol of labeled inhibitor (5α and 5β)
for 60 min at 25°C. The suspension was centrifuged (100,000  g at 4°C) for 30 min, and the pellet was transferred to a 4-mm external diameter zirconia MAS rotor fitted with Kel-F inserts to confine the sample to the center of the rotor. In ouabain pre-incubation experiments, the membranes were first incubated with ouabain for 1h, then the same amount of 5β was added and further incubated for 1h. Detailed hydrogen bonds in compounds 1α,1β, 4α, 4β, 5α and 5β 
